UB addiction specialist Clara Bradizza appointed to NIH study section

Clara Bradizza, senior research scientist in UB's Research Institute on Addictions.

Clara Bradizza, senior research scientist in UB's Research Institute on Addictions, has been appointed to a two-year term on the Interventions to Prevent and Treat Addictions Study Section of the NIH's Center for Scientific Review.

By Cathy Wilde

Release Date: January 12, 2018 This content is archived.

Print
“Dr. Bradizza’s appointment to the study section is a testament to her noteworthy achievements in the study of alcohol and nicotine use disorders, particularly in finding innovative treatment strategies involving emotional regulation.”
Kenneth Leonard, director, Research Institute on Addictions
University at Buffalo

BUFFALO, N.Y. -- Clara Bradizza, PhD, senior research scientist in the University at Buffalo Research Institute on Addictions, has been selected to serve as a member of the Interventions to Prevent and Treat Addictions Study Section of the National Institutes of Health’s Center for Scientific Review.

Study sections review grant applications submitted to the NIH, make recommendations to NIH advisory councils or boards, and survey the status of research in their fields of science. Bradizza will serve a two-year term beginning July 1, 2018, and ending June 30, 2020, and will review applications for human research aimed at preventing addiction and treating substance use disorders, including curtailing the progression of substance use to dependence or abuse, and preventing relapse.

“Dr. Bradizza’s appointment to the study section is a testament to her noteworthy achievements in the study of alcohol and nicotine use disorders, particularly in finding innovative treatment strategies involving emotional regulation,” says Kenneth Leonard, RIA director.

Bradizza’s current research includes projects that span alcohol, tobacco and e-cigarette products. She is currently involved as a multiple principal investigator on a study testing an affect regulation intervention for alcohol use disorders, and has completed a treatment development study of an affect regulation intervention for pregnant smokers. In addition, she is collaborating on two studies investigating the impact of pretreatment change on treatment outcomes and a tailored treatment approach that is responsive to pretreatment change among alcohol dependent individuals.

She recently co-authored two books for treatment professionals, “Emotion Regulation Treatment of Alcohol Use Disorders: Helping Clients Manage Negative Thoughts and Feelings” and “Managing Negative Emotions Without Drinking: A Workbook of Effective Strategies.”

An adjunct research faculty member in UB’s Department of Family Medicine, Bradizza received a master’s degree and doctorate in clinical psychology from Binghamton University.

RIA is a research center of the University at Buffalo and a national leader in the study of alcohol and substance abuse issues. RIA’s research programs, most of which have multiple-year funding, are supported by federal, state and private foundation grants. Located on UB’s Downtown Campus, RIA is a member of the Buffalo Niagara Medical Campus and a key contributor to UB’s reputation for research excellence. To learn more, visit buffalo.edu/ria

Media Contact Information

Cathy Wilde no longer works for UB. To contact Clinical and Research
Institute on Addictions staff, call 716-887-2566 or visit the RIA website Sorry for the inconvenience.